134
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

In Vivo Evaluation of Eclipta alba Extract as Anticancer and Multidrug Resistance Reversal Agent

, &
Pages 904-913 | Received 13 Jul 2013, Accepted 10 Mar 2014, Published online: 04 Jun 2014

REFERENCES

  • Choi CH: ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 5, 30, 2005.
  • Karin M: Nuclear factor-kB in cancer development and progression. Nature 441, 431–436, 2006.
  • Lu Y and Wahl LM: Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J Immunol 175, 5423–5429, 2005.
  • Melisi D and Chiao PJ: NF-κB as a target for cancer therapy. Expert Opin Ther Targets 11, 133–144, 2007.
  • Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, et al.: Nf-kB transcription factor induces drug resistance through mdr1 expression in cancer cells. Oncogene 22, 90–97, 2003.
  • Garg AK, Buchhloz TA, and Aggarwal BB: Chemosensitization and radio sensitization of tumors by plant polyphenols. Antioxid Redox Sign 7, 1630–1647, 2005.
  • Chaudhary H, Dhuna V, Singh J, Kamboj SS, and Seshadri S: Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: an in vitro study. J Ethnopharmocol 136, 363–367, 2011.
  • Chaudhary H., Jena PK, and Seshadri S: Evaluation of hydro-alcoholic extract of Eclipta alba for its multidrug resistance reversal potential: an in vitro study. Nutr Cancer 65, 775–780, 2013.
  • Leal LKAM, Ferreira AAG, Bezerra GA, Matos FJA, and Viana GSB: Antinociceptive, anti-inflammatory and bronchodilator activities of Brazilian medicinal plants containing coumarin: a comparative study. J Ethnopharmacol 70, 151–159, 2000.
  • INSA: Indian National Science Academy, New Delhi, 2000.
  • Patricia AM, van Snoek B, Johannes W, and Von den H: Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. BioTechniques 38, 73–83, 2005.
  • Wu W, Yao D, Wang Y, Qiu L, Sai W, et al.: Suppression of human hepatoma (HepG2) cell growth by nuclear factor-kappaB/p65 specific siRNA. Tumour Biol 31, 605–611, 2010.
  • Verna L, Whysner J, Williams GM: N-nitrosodiethylamine mechanistic data and risk asseessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 71, 57–81, 1996.
  • Wyllie AH, Kerr JF, and Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68, 251–306, 1980.
  • Ikeguchi M, Hirooka Y, and Kaibara N: Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Cancer 95, 1938–1945, 2002.
  • Osaki I, Yamamoto K, Mizuta T, Setoguchi Y, Morito F, et al.: Detection of matrix metalloproteinase gene expression by reverse transcription polymerase chain reaction in human hepatocellular carcinomas. Int Hepatol Commun 6, 36–42, 1996.
  • Musso O, Theret N, Campion JP, Turlin B, Milani S, et al.: In situ detection of matrix metalloproteinase-2 (MMP-2), and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma, and in liver metastasis. J Hepatol 26, 593–605, 1997.
  • Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, and Larjava H: Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 (72 kDa and 92 kDa type IV collagenases) during early human wound healing. Lab Invest 70, 176–182, 1994.
  • Hoyhtya M, Hujanen E, Turpeenniemi-Hujanen T, Thorgeirsson U, Liotta LA, et al.: Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase. Int J Cancer 46, 282–286, 1990.
  • Morgan MJ and Liu ZG: Crosstalk of reactive oxygen species and NF-kB signaling. Cell Res 21, 103–115, 2011.
  • Jedlitschky G, Leier I, Buchholz U, Center M, and Keppler D: ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54, 4833–4836, 1994.
  • Wartenberg M, Ling FC, Schallenberg M, Baumer AT, Petrat K, et al.: Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species. J Biol Chem 276, 17420–17428, 2001.
  • Hu YP and Robert J: Inhibition of protein kinase C in multidrug resistant cells by modulators of multidrug resistance. J Cancer Res Clin Oncol 123, 201–210, 1997.
  • Parola M and Robino G: Oxidative stress-related molecules and liver fibrosis. J Hepatol 35, 297–306, 2001.
  • Bulle F, Mavier P, Zafrani ES, Preaux AM, Lescs MC, et al.: Mechanism of gamma-glutamyltranspeptidase release in serum during intrahepatic and extra-hepatic cholestasis in the rat: a histochemical, biochemical and molecular approach. Hepatol 11, 545–550, 1990.
  • Liu Y, Butterfield LH, Fu X, Song, Z. Zhang X, et al.: Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo. Int J Oncol 39, 245–253, 2011.
  • Den-Hartog GJ, Boots AW, Adam-Perrot A, Brouns F, Verkooijen IW, et al.: Erythritol is a sweet antioxidant. Nutri 26, 449–458, 2010.
  • Gong W, Xiong G, and Maser E: Oligomerization and negative autoregulation of the LysR-type transcriptional regulator HsdR from Comamona stestosteroni. J Steroid Biochem Mol Biol 132, 203–211, 2012.
  • Spiller GA (Ed.): CRC Handbook of Lipids in Human Nutrition. Boca Raton, FL: CRC Press, 1996.
  • Lalitharani S, Mohan VR, Regini GS, and Kalidass C: GC-MS analysis of ethanolic extract of Pothosscandens leaf. J Herbal Med Toxicol 3, 159–160, 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.